XML 35 R21.htm IDEA: XBRL DOCUMENT
v3.19.1

15. Parent Company Financial Statements (Unaudited) | 12 Months Ended
--- | ---
Dec. 31, 2018
Condensed Financial Information Disclosure [Abstract] |
Parent Company Financial Statements (Unaudited) | The following is a summary of the Parent Company financial statements for the years ended December 31, 2018 and 2017: Aemetis, Inc. (Parent Company) Balance Sheets As of December 31, 2018 and 2017
Assets |  | 2018 |  |  | 2017 |
Current assets |  |  |  |  |  |
Cash and cash equivalents |  | $ | - |  |  | $ | 29 |
Receivables due from subsidiaries |  |  | 5,057 |  |  |  | 6,946 |
Prepaid expenses |  |  | 364 |  |  |  | 251 |
Total current assets |  |  | 5,421 |  |  |  | 7,226 |
Investment in AE Advanced Products Keyes , Inc. |  |  | 1,057 |  |  |  | 1,617 |
Total investments in Subsidiaries, net of advances |  |  | 1,057 |  |  |  | 1,617 |
Property, plant and equipment, net |  |  | 12 |  |  |  | 15 |
Other assets |  |  | 54 |  |  |  | 54 |
Total Assets |  | $ | 6,544 |  |  | $ | 8,912 |
Liabilities & stockholders' deficit |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |
Accounts payable |  | $ | 5,026 |  |  | $ | 3,568 |
Mandatorily redeemable Series B convertible preferred |  |  | 3,048 |  |  |  | 2,946 |
GAFI- payables, net of SARs discount issuance costs |  |  | 1,090 |  |  |  | 3,357 |
SARs liability |  |  | 1,132 |  |  |  | - |
Other current liabilities |  |  | 2,215 |  |  |  | 1,679 |
Total current liabilities |  |  | 12,511 |  |  |  | 11,550 |
Subsidiary obligation in excess of investment |  |  |  |  |  |  |  |
Investment in AE Advanced Fuels, Inc. |  |  | 89,854 |  |  |  | 69,273 |
Investment in Aemetis Americas, Inc |  |  | 205 |  |  |  | 205 |
Investment in Aemetis Biofuels, Inc. |  |  | 2,738 |  |  |  | 2,738 |
Investment in Aemetis Technologies, Inc. |  |  | 4,030 |  |  |  | 2,947 |
Investment in Aemetis Property Keyes, Inc. |  |  | 432 |  |  |  | 100 |
Investment in Biofuels Marketing, Inc. |  |  | 349 |  |  |  | 349 |
Investment in Aemetis International, Inc. |  |  | 963 |  |  |  | 142 |
Investment in Aemetis Biogas LLC |  |  | 6,304 |  |  |  | - |
Total subsidiary obligation in excess of investment |  |  | 104,875 |  |  |  | 75,754 |
Stockholders' deficit |  |  |  |  |  |  |  |
Series B Preferred convertible stock |  |  | 1 |  |  |  | 1 |
Common stock |  |  | 20 |  |  |  | 20 |
Additional paid-in capital |  |  | 85,917 |  |  |  | 84,679 |
Accumulated deficit |  |  | (193,204 | ) |  |  | (160,188 | )
Accumulated other comprehensive loss |  |  | (3,576 | ) |  |  | (2,904 | )
Total stockholders' deficit |  |  | (110,842 | ) |  |  | (78,392 | )
Total liabilities & stockholders' deficit |  | $ | 6,544 |  |  | $ | 8,912 |
Aemetis, Inc. (Parent Company) Statements of Operations and Comprehensive Loss For the Years Ended December 31, 2018 and 2017
|  | 2018 |  |  | 2017 |
Equity in subsidiary losses |  | $ | (29,009 | ) |  | $ | (22,341 | )
Selling, general and administrative expenses |  |  | 8,742 |  |  |  | 7,317 |
Operating loss |  |  | (37,751 | ) |  |  | (29,658 | )
Other expense |  |  |  |  |  |  |  |
Interest expense |  |  | 1,281 |  |  |  | 503 |
Other (income) expense |  |  | (6,023 | ) |  |  | 134 |
Loss before income taxes |  |  | (33,009 | ) |  |  | (30,295 | )
Income tax expense |  |  | 7 |  |  |  | 6 |
Net loss |  |  | (33,016 | ) |  |  | (30,301 | )
Other comprehensive loss |  |  |  |  |  |  |  |
Foreign currency translation adjustment |  |  | (672 | ) |  |  | 484 |
Comprehensive loss |  | $ | (33,688 | ) |  | $ | (29,817 | )
Aemetis, Inc. (Parent Company) Statements of Cash Flows For the years ended December 31, 2018 and 2017
|  | 2018 |  |  | 2017 |
Operating activities: |  |  |  |  |  |
Net loss |  |  | (33,016 | ) |  |  | (30,301 | )
Adjustments to reconcile net loss to net cash used in operating activities: |  |  |  |  |  |  |  |
Stock-based compensation |  |  | 981 |  |  |  | 1,101 |
Stock issued for services |  |  | 22 |  |  |  | 118 |
SARs Amortization |  |  | 477 |  |  |  | - |
Depreciation |  |  | 8 |  |  |  | 6 |
Subsidiary portion of net losses |  |  | 29,009 |  |  |  | 22,341 |
Change in fair value of SARs liability |  |  | (145 | ) |  |  |  |
Changes in assets and liabilities: |  |  |  |  |  |  |  |
Prepaid expenses |  |  | (113 | ) |  |  | 19 |
Accounts payable |  |  | 1,459 |  |  |  | 529 |
Accrued interest expense |  |  | 209 |  |  |  | 503 |
Other liabilities |  |  | 275 |  |  |  | 64 |
Net cash used in operating activities |  |  | (834 | ) |  |  | (5,620 | )
Investing activities: |  |  |  |  |  |  |  |
Subsidiary advances, net |  |  | 2,119 |  |  |  | 5,149 |
Net cash provided by investing activities |  |  | 2,119 |  |  |  | 5,149 |
Financing activities: |  |  |  |  |  |  |  |
Proceeds from borrowings under secured debt facilities |  |  | 1,500 |  |  |  | 500 |
Repayments of borrowings under secured debt facilities |  |  | (2,814 | ) |  |  | - |
Net cash (used)/provided by financing activities |  |  | (1,314 | ) |  |  | 500 |
Net increase (decrease) in cash and cash equivalents |  |  | (29 | ) |  |  | 29 |
Cash and cash equivalents at beginning of period |  |  | 29 |  |  |  | - |
Cash and cash equivalents at end of period |  | $ | - |  |  | $ | 29 |
Supplemental disclosures of cash flow information, cash paid: |  |  |  |  |  |  |  |
Interest payments |  |  | - |  |  |  | - |
Income tax expense |  |  | 7 |  |  |  | 6 |
Supplemental disclosures of cash flow information, non-cash transactions: |  |  |  |  |  |  |  |
Fair value of warrants issued to subordinated debt holders |  |  | 235 |  |  |  | 321 |
Repurchase of common stock added to TEC promissory note |  |  | - |  |  |  | 451 |
Payment of TEC bridge loan added to GAFI Revolving loan |  |  | - |  |  |  | 3,669 |
Stock Appreciation Rights issued for GAFI Amendment No. 1 |  |  | 1,277 |  |  |  | - |
Settlement of subordinated debt through issuing stock |  |  | - |  |  |  | 132 |

X
- References No definition available. + Details
Name: | srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=108774443&loc=d3e5283-111683 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 235 -Section S99 -Paragraph 2 -Subparagraph (SX 210.9-06) -URI http://asc.fasb.org/extlink&oid=6882215&loc=d3e537971-122884 + Details
Name: | us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration